Fig. 2From: A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancerA patient with a small difference in BSI at two different examinations performed 6 days apart. The upper row shows the bone scan (anterior and posterior views) after the first (left) and second (right) examinations. The lower row shows the hotspots automatically detected by the EXINI software. Blue lesions are not considered metastatic (and thus not included in the BSI measurement), and red lesions are considered metastaticBack to article page